These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2096187)

  • 21. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    West J Med; 1990 May; 152(5):506-13. PubMed ID: 2190418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing for drugs of abuse in the physician office laboratory.
    Bachman A
    Tenn Med; 2011 Feb; 104(2):47. PubMed ID: 21387898
    [No Abstract]   [Full Text] [Related]  

  • 23. Exhaled breath for drugs of abuse testing - evaluation in criminal justice settings.
    Beck O
    Sci Justice; 2014 Jan; 54(1):57-60. PubMed ID: 24438778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mandatory drug testing in the United States. Opportunities and challenges for the medical review officer.
    Gerson B; Hahn R
    Clin Lab Med; 1990 Sep; 10(3):517-29. PubMed ID: 2253448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of physicians as medical review officers in workplace drug testing programs. In pursuit of the last nanogram.
    Clark HW
    West J Med; 1990 May; 152(5):514-24. PubMed ID: 2190419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Present and future opportunities.
    Kenney JE
    Occup Health Saf; 2005 Aug; 74(8):84, 86. PubMed ID: 16212029
    [No Abstract]   [Full Text] [Related]  

  • 27. Urine drug screening: a valuable office procedure.
    Standridge JB; Adams SM; Zotos AP
    Am Fam Physician; 2010 Mar; 81(5):635-40. PubMed ID: 20187600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. To test or not to test? Social welfare versus worker freedom.
    Baumrin BH
    J Psychoactive Drugs; 1990; 22(4):485-7. PubMed ID: 2096193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice.
    Fed Regist; 1991 Jan; 56(1):77-8. PubMed ID: 10128596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The current status of drug testing in the U.S. workforce.
    Wong R
    Am Clin Lab; 2002 Apr; 21(3):14-7. PubMed ID: 12038079
    [No Abstract]   [Full Text] [Related]  

  • 32. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--HHS. Notice.
    Fed Regist; 1990 Oct; 55(190):40008-9. PubMed ID: 10107029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Legal issues facing physicians: substance abuse in the workplace.
    Clark HW; Johnson B
    Occup Med; 2002; 17(1):119-35, v. PubMed ID: 11726341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory guidelines in analytical toxicology: how to approach qualitative analysis.
    de Zeeuw RA
    J Forensic Sci; 1992 Nov; 37(6):1437-42. PubMed ID: 1453159
    [No Abstract]   [Full Text] [Related]  

  • 35. Value of hair analysis in postmortem toxicology.
    Kintz P
    Forensic Sci Int; 2004 Jun; 142(2-3):127-34. PubMed ID: 15172076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations for toxicological investigation of drug impaired driving.
    Farrell LJ; Kerrigan S; Logan BK
    J Forensic Sci; 2007 Sep; 52(5):1214-8. PubMed ID: 17680796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adulterants and drugs-of- abuse testing: an update.
    Dasgupta A
    MLO Med Lab Obs; 2008 Feb; 40(2):24-5. PubMed ID: 18405221
    [No Abstract]   [Full Text] [Related]  

  • 38. Do we have the training? The ethics of workplace drug testing and the GP.
    Evans A; Thornett A
    Aust Fam Physician; 2003 Aug; 32(8):645-7. PubMed ID: 12973876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Scope, Quality and Safety Requirements of Drug Abuse Testing].
    Küme T; Karakükcü Ç; Pınar A; Coşkunol H
    Turk Psikiyatri Derg; 2017; 28(3):198-207. PubMed ID: 28936819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky.
    Gilbert JW; Wheeler GR; Mick GE; Storey BB; Herder SL; Richardson GB; Watts E; Gyarteng-Dakwa K; Marino BS; Kenney CM; Siddiqi M; Broughton PG
    Pain Physician; 2010; 13(2):167-86. PubMed ID: 20309383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.